A CLINICAL TRAIL TO COMPARE LOW DOSE PROPOFOL AND ETOMIDATE ON VARIOUS PARAMETERS OF ELECTROCONVULSIVE THERAPY
Phase 1
Completed
- Registration Number
- CTRI/2022/01/039097
- Lead Sponsor
- Dr Praveen Onimath
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 44
Inclusion Criteria
ASA Physical status I and II
Age 20-65 years
Informed valid written consent taken from patients attenders
Exclusion Criteria
History of allergy to given drug
History of cardiovascular diseases
History of cerebrovascular diseases with raised ICT
Uncontrolled seizures on antiepileptics
Patients on pacemaker
Neuromuscular diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effects of low dose propofol and etomidate on seizure duration and seizure thresholdTimepoint: HR, BP, SPO2 are noted after the administration of study drug, after giving succinylcholine, then after ECT, at 1, 3, 5,7, 10 min, and then every 5 min throughout the procedure.
- Secondary Outcome Measures
Name Time Method To study hemodynamic data recovery characteristics and adverse effects if any.Timepoint: Hemodynamic data during the procedure and recovery characteristics and adverse effects at end of the procedure are seen.